Literature DB >> 24381361

Accuracy of physician reporting in routine public health surveillance for hepatitis C virus infection.

Klaus Jochem1, Pascale Leclerc2, Emilie Maurais1, Claude Tremblay1, Joseph Cox3.   

Abstract

OBJECTIVE: From January 2007 to December 2008, the Montréal Public Health Department sent postal questionnaires to physicians and conducted patient interviews for all those newly diagnosed with hepatitis C virus (HCV) infection. We evaluated physician responses to risk factor questions for non-acute HCV cases.
METHODS: We compared physician and patient responses with each of nine risk factor questions, determined the sensitivity and specificity of physician responses compared with patient responses, and evaluated agreement using Gwet's agreement coefficient (AC1). We ranked risk factors and compared the distributions by principal exposure category according to physician reporting vs. patient interview using the Chi-square test.
RESULTS: The completeness of physicians' responses (yes, no, or unknown) varied by risk factor question from 90.8% to 96.7%. For risk factors present among more than 5% of cases, sensitivity of physician responses ranged from 26.9% to 87.7% and specificity ranged from 93.0% to 98.6%. The AC1 coefficients for agreement between physician and patient responses to lifetime risk factors considered most important in HCV acquisition were 0.80 for injection drug use, 0.95 for blood transfusion before 1990, and 0.86 for birth in a country with high HCV prevalence. Risk distributions by principal exposure category according to physician reporting vs. patient interview were not statistically different (χ(2)[4] = 2.17, p=0.704).
CONCLUSION: Postal questionnaires completed by physicians appear valid for determining the principal exposure category among non-acute HCV cases. Physician reporting can be a useful and low-cost component of routine HCV surveillance.

Entities:  

Mesh:

Year:  2014        PMID: 24381361      PMCID: PMC3863005          DOI: 10.1177/003335491412900110

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  21 in total

1.  Hepatitis C--global prevalence (update).

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2000-01-21

Review 2.  Unsafe injections in the developing world and transmission of bloodborne pathogens: a review.

Authors:  L Simonsen; A Kane; J Lloyd; M Zaffran; M Kane
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

3.  Enhanced surveillance of newly acquired hepatitis C virus infection in Canada, 1998 to 2004.

Authors:  Hong-Xing Wu; Jun Wu; Tom Wong; Tracey Donaldson; Katherine Dinner; Anton Andonov; Jessica Ip Chan; Barbara Moffat; Beverley Baptiste; Janet Furseth; Darlene Poliquin; Grlica Bolesnikov; Antonio Giulivi; Shirley Paton
Journal:  Scand J Infect Dis       Date:  2006

4.  The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings.

Authors:  David B Rein; Bryce D Smith; John S Wittenborn; Sarah B Lesesne; Laura D Wagner; Douglas W Roblin; Nita Patel; John W Ward; Cindy M Weinbaum
Journal:  Ann Intern Med       Date:  2011-11-04       Impact factor: 25.391

5.  Hepatitis C identification and management by family physicians.

Authors:  Elizabeth C Clark; Barbara P Yawn; James M Galliher; Jonathan L Temte; John Hickner
Journal:  Fam Med       Date:  2005-10       Impact factor: 1.756

Review 6.  Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review.

Authors:  Daniele Prati
Journal:  J Hepatol       Date:  2006-07-25       Impact factor: 25.083

7.  Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.

Authors:  Sheila F O'Brien; Qi-Long Yi; Wenli Fan; Vito Scalia; Steven H Kleinman; Eleftherios C Vamvakas
Journal:  Transfusion       Date:  2007-02       Impact factor: 3.157

8.  Enhanced surveillance of acute hepatitis B and C in four health regions in Canada, 1998 to 1999.

Authors:  S Zou; J Zhang; M Tepper; A Giulivi; B Baptiste; G Predy; D Poliquin; M Morin; D Jones; J Lowewen; M Ogonowski; S Moses; L Elliott
Journal:  Can J Infect Dis       Date:  2001-11

9.  Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality.

Authors:  Yasuhito Tanaka; Fuat Kurbanov; Shuhei Mano; Etsuro Orito; Victor Vargas; Juan I Esteban; Man-Fung Yuen; Ching-Lung Lai; Anna Kramvis; Michael C Kew; Heidi E Smuts; Sergey V Netesov; Harvey J Alter; Masashi Mizokami
Journal:  Gastroenterology       Date:  2006-03       Impact factor: 22.682

Review 10.  Surveillance and epidemiology of hepatitis B and C in Europe - a review.

Authors:  Merja Rantala; M J W van de Laar
Journal:  Euro Surveill       Date:  2008-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.